ALXO   $1.49  0.68% Market Closed After Close 1.5 0.67%

ALX Oncology Holdings Inc
Total Cash 156.72M
totalCashPerShare 2.975
EBITDA -179.51M
Total Debt 17.47M
quickRatio 4.238
currentRatio 4.388
Total Revenue
debtToEquity 10.967
Revenue/Share
ROA -0.49013
ROE -0.92170995
grossProfits
freeCashflow -69.02M
operatingCashflow -135.33M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -61.30M
forwardPE -0.5208333
floatShares 27.07M
sharesOutstanding 52.67M
sharesShort 9.32M
sharesShortPriorMonth 9.98M
dateShortInterest
sharesPercentSharesOut 0.18%
heldPercentInsiders 0.02%
heldPercentInstitutions 1.07%
Short Ratio help_outline 16.81%
shortPercentOfFloat 0.31%
impliedSharesOutstanding
bookValue 3.037
Price To Book help_outline 0.49
earningsQuarterlyGrowth
netIncomeToCommon -171.44M
trailingEps -3.64%
forwardEps -2.88%
enterpriseToEbitda 0.34
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.78 3Q 2024
institutionsCount 167
lastUpdated Oct. 22, 2024, 12:13 a.m.